Liangping Li

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Regulatory T Cells

Aortic Valve Replacement

Squamous Cell Carcinoma

Top Venues

Stem cell research & therapy

Cancer immunology, immunotherapy : CII

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Qingyang Li, Wei Hu, Baoyi Liao, Chanchan Song, Liangping Li
Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers. Journal for immunotherapy of cancer 10 (7) (2022)
Chanchan Song, Linli Wang, Qingyang Li, Baoyi Liao, Weihua Qiao, Qiang Li, Nianguo Dong, Liangping Li
Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells. Stem cell research & therapy 13 (1) (2022)
Chanchan Song, Linli Wang, Qingyang Li, Baoyi Liao, Weihua Qiao, Qiang Li, Nianguo Dong, Liangping Li
Correction to: Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells. Stem cell research & therapy 13 (1) (2022)
Junxia Gao, Xianlin Yuan, Jia Yuan, Liangping Li
Complete rejection of large established breast cancer by local immunochemotherapy with T cell activation against neoantigens. Cancer immunology, immunotherapy : CII 70 (11) (2021)